Sun Pharmaceutical DOXOrubin Liposome Injection Recall: Glass Particulate Risk

Take action

Contact the company & request your remedy

Recalling firmSUN PHARMACEUTICAL INDUSTRIES INC2 Independence Way, N/A · Princeton, NJ 08540-6620

No email on file — write to the address above instead.

✎ GovInfoNow plain-language explainer

What happened, in plain English

Sun Pharmaceutical is recalling DOXOrubin Hydrochloride Liposome injections because glass particles were found in the product. This could cause serious injury if injected. The recall applies to specific lots manufactured for Northstar Rx LLC.

Why it’s dangerous

Glass particles in the injection can cause serious injury when injected, such as tissue damage or blockages. This is a critical hazard because the product is used for medical treatment and particles can enter the bloodstream.

Who’s affected

Prescription patients who have the specific lot number HAG2581B of DOXOrubin Hydrochloride Liposome injections. Healthcare providers using this product are most at risk.

How to tell if you have this one

Check the lot number on the vial label, which should be HAG2581B. The product expires May 31, 2027, and is a 25 mL single-dose vial for prescription use.

Brand
Sun Pharmaceutical
Category
Drug

Based on the official FDA remedy

What to do — step by step

Stop Using Now
Immediately stop using the recalled DOXOrubin Hydrochloride Liposome injection vials with lot number HAG2581B.

✎ GovInfoNow

Questions people ask

What is the specific lot number for this recall?

The recalled lot number is HAG2581B.

How can I check if I have the recalled product?

Check the lot number on the vial label; the recalled product has lot number HAG2581B and expires May 31, 2027.

Is there a remedy for this recall?

The recall record does not specify a remedy.

Take action

Contact Sun Pharmaceutical

We’ve drafted a message you can send Sun Pharmaceutical to request your refund or repair — edit it as you like.

✉️ Open in email

Subject: Recall D-0580-2026 — Sun Pharmaceutical Sun Pharmaceutical

Hello,

I own a Sun Pharmaceutical that is covered by recall D-0580-2026 from Sun Pharmaceutical.

I’m writing to arrange the remedy described in the recall (a refund, repair, or replacement as applicable). Could you please tell me the next steps to resolve this?

Thank you.

Similar recalls

From people who’ve dealt with this

Experiences, tips, and questions from readers. Every comment is reviewed before it appears.

No comments yet — be the first to share your experience.

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

Official source: FDA Recall #D-0580-2026 (May 12, 2026) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0580-2026 to see it in context.
Plain-language summary written by qwen3:4b on August 17, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.

SUN PHARMACEUTICAL INDUSTRIES INC recalls DOXOrubin Hydrochloride Liposome injection, 50 mg/25 mL (2mg/mL), 25 mL single-dose vials, Sterile, Rx only,

Stop using this now